Literature DB >> 17666066

Autonomic tone attenuates drug-induced QT prolongation.

Andrew H Smith1, Kris J Norris, Dan M Roden, Prince J Kannankeril.   

Abstract

INTRODUCTION: The QT interval is a predictor of sudden death. Many drugs prolong the QT, primarily through I(Kr) block. Autonomic tone directly affects heart rate and ventricular repolarization, but its effects in the setting of I(Kr) block are unknown.
OBJECTIVE: Determine the effects of autonomic tone on heart rate and QT interval after I(Kr) block. METHODS AND
RESULTS: Healthy adults (n = 9) were administered ibutilide with ECGs obtained at regular intervals. On a separate day, subjects were administered intravenous propranolol and atropine to induce autonomic block, resulting in intrinsic heart rate and QT interval; ibutilide was administered again, with serial ECGs obtained at regular intervals. No differences in baseline RR, QT, or QTc intervals were seen between the two study days. Ibutilide in the setting of intact autonomic tone prolonged QTc by 43 +/- 8 msec (P = 0.001) and prolonged RR interval by 93 +/- 39 msec (P = 0.04). Autonomic block alone on the second day prolonged QTc by 16.7 +/- 9.4 msec (P = 0.02). An additional 68 +/- 5 msec prolongation of QTc was seen with ibutilide in the setting of double autonomic block (P = 0.036). There was no effect of ibutilide on intrinsic heart rate (P = 0.125).
CONCLUSION: Autonomic block results in an exaggeration of drug-induced QT prolongation by ibutilide. I(Kr) block has no effect on intrinsic heart rate. QT-prolonging drugs may have more deleterious effects in those with underlying autonomic dysfunction, thus increasing the risk for sudden death.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17666066     DOI: 10.1111/j.1540-8167.2007.00901.x

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  8 in total

1.  Factors affecting the degree of QT prolongation with drug challenge in a large cohort of normal volunteers.

Authors:  Prince J Kannankeril; Kris J Norris; Shannon Carter; Dan M Roden
Journal:  Heart Rhythm       Date:  2011-03-21       Impact factor: 6.343

2.  Iatrogenic QT Abnormalities and Fatal Arrhythmias: Mechanisms and Clinical Significance.

Authors:  Luigi X Cubeddu
Journal:  Curr Cardiol Rev       Date:  2009-08

3.  Electrocardiographic effects of lofexidine and methadone coadministration: secondary findings from a safety study.

Authors:  John Schmittner; Jennifer R Schroeder; David H Epstein; Mori J Krantz; Nicole C Eid; Kenzie L Preston
Journal:  Pharmacotherapy       Date:  2009-05       Impact factor: 4.705

4.  LMI1195 PET imaging in evaluation of regional cardiac sympathetic denervation and its potential role in antiarrhythmic drug treatment.

Authors:  Ming Yu; Jody Bozek; Melanie Lamoy; Mikhail Kagan; Pedro Benites; David Onthank; Simon P Robinson
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-08-04       Impact factor: 9.236

5.  Short-term secondhand smoke exposure decreases heart rate variability and increases arrhythmia susceptibility in mice.

Authors:  Chao-Yin Chen; Drin Chow; Nipavan Chiamvimonvat; Kathryn A Glatter; Ning Li; Yuxia He; Kent E Pinkerton; Ann C Bonham
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-06-13       Impact factor: 4.733

6.  Modulation of the heart's electrical properties by the anticonvulsant drug retigabine.

Authors:  Lena Rubi; Michael Kovar; Eva Zebedin-Brandl; Xaver Koenig; Manuel Dominguez-Rodriguez; Hannes Todt; Helmut Kubista; Stefan Boehm; Karlheinz Hilber
Journal:  Toxicol Appl Pharmacol       Date:  2017-06-20       Impact factor: 4.219

Review 7.  Drug-induced Inhibition and Trafficking Disruption of ion Channels: Pathogenesis of QT Abnormalities and Drug-induced Fatal Arrhythmias.

Authors:  Luigi X Cubeddu
Journal:  Curr Cardiol Rev       Date:  2016

8.  Corrected QT interval prolongation during anesthetic induction for laryngeal mask airway insertion with or without cisatracurium.

Authors:  Chengluan Xuan; Nan Wu; Yanhui Li; Xiaoting Sun; Qunshu Zhang; Haichun Ma
Journal:  J Int Med Res       Date:  2018-03-27       Impact factor: 1.671

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.